Overview A Phase 4 Study of Imrecoxib in Treatment of Knee Osteoarthritis Status: Unknown status Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the efficacy and safety of Imrecoxib in the treatment of patients with knee osteoarthritis. Phase: Phase 4 Details Lead Sponsor: Jiangsu HengRui Medicine Co., Ltd.